Prime Medicine, Inc. Common Stock (PRME) — Capital Reinvestment Ratio

Latest as of December 2024: 0.11x

Prime Medicine, Inc. Common Stock (PRME) has a Capital Reinvestment Ratio of 0.11x as of December 2024, meaning it reinvests 0% of its operating cash flow ($16.25 Million) in capital expenditures ($1.79 Million). See how leveraged is Prime Medicine, Inc. Common Stock's balance sheet to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.11x

Capex / Operating Cash Flow

Operating Cash Flow

$16.25 Million

USD

Capital Expenditures

$1.79 Million

USD

Data as of

Dec 2024

Most recent filing

Annual Capital Reinvestment Ratio for Prime Medicine, Inc. Common Stock (None–None)

Year-by-year Capital Reinvestment Ratio for Prime Medicine, Inc. Common Stock from None to None. For live market cap and broader valuation context, see Prime Medicine, Inc. Common Stock (PRME) market capitalisation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow